Skip to main content

P-ANCA as a Diagnostic Marker in Ulcerative Colitis

  • Chapter
ANCA-Associated Vasculitides

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 336))

Summary

P-ANCA that do not react with myeloperoxidase (MPO) have been claimed to serve as a useful diagnostic marker in the differential diagnosis of inflammmatory bowel disease (IBD). Therefore, in this study we determined the frequency of MPOnegative-p-ANCA in patients with inflammatory bowel disease and correlated the presence with intestinal and extra-intestinal disease manifestation. In 44 out of 65 (68%) sera from patients with ulcerative colitis (UC) but in only 14 of 66 (21%) with Crohn’s disease (CD) MPO-negative-p-ANCA were detected whereby colonic involvement and extraintestinal manifestations seemed to be important. There was no correlation to therapy, activity, sex, age, extent and duration of disease. Moreover, the sera did not exhibit significant reactivity in ELISAs testing for Cathepsin G-, Lactoferrin-, Myeloperoxidase-, Elastase- or Proteinase 3- specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mille B., Specks U., Lüdemann J., Rohrbach M.S., DeRemee R.A., Gross W.L., 1989, Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener Granulomatosis, Ann. Int. Med. 111: 28-40

    Google Scholar 

  2. Lesavre P., 1991, Antineutrophil cytoplasmic autoantibodies antigen specificity, Am. J. Kid. Dis. 18, 2: 159 - 163

    PubMed  CAS  Google Scholar 

  3. Falk R.J., Hogan S.L., Wilkman A.S., Terrell R.S., Lauritzen S., Charles L.A., Jennette J.C., 1990, Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA). Nether]. J. Med. 36: 121-125

    Google Scholar 

  4. Falk R.J, Jennette J.C., 1988, Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic Glomerulonephritis. N. Engl. J. Med. 318, 25: 1651 - 1657

    Article  PubMed  CAS  Google Scholar 

  5. Duerr R.H., Targan S.R., Landers C.J, Sutherland L.R., Shanahan F., 1991, Anti-Neutrophil Cytoplasmic Antibodies in Ulcerative Colitis, Gastroenterol., 100: 1590 - 1596

    CAS  Google Scholar 

  6. Duerr R.H., Targan S.R., Landers C.J., Larusso N.F., Lindsay K.L., Wiesner R.H., Shanahan F., 1991, Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterol., 100: 1385-1391

    Google Scholar 

  7. Saxon A., Shanahan F., Landers C., Ganz T., Targan S., 1990, A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J. Allergy Clin. Immunol. 86,2: 202 - 210

    Google Scholar 

  8. Rump J.A., Schölmerich J., Gross V., Roth M., Helfersrieder R., Rautmann A., Lüdemann J., Gross W.L., Peter H.H., 1990, A new type of perinuclear antineutrophil cytoplasmic antibody (pANCA) in active ulcerative colitis but not in Crohn’s disease. Immunobiol. 181: 406 - 413

    Article  CAS  Google Scholar 

  9. Zauli D., Baffoni L., Cassani F., Fusconi M., Lenzi M., Ballardini G., Luigi M., Bianchi F.B., 1992, Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases. Gastoenterol. 102: 1088 - 1089

    CAS  Google Scholar 

  10. Snook J.A., Chapman R.W., Fleming K., Jewell D.P., 1989, Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn’s disease and primary sclerosing cholangitis Clin. Exp. Immunol. 76: 3033

    Google Scholar 

  11. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C., 1990, Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro, Proc. Nat]. Acad. Sci. 87: 4115-4119

    Google Scholar 

  12. Wakefield A.J., Sawyer A.M., Dhillon A.P., 1989, Pathogenesis of Crohn s disease: multifocal gastrointestinal infarction. Lancet 2: 1057 - 1062

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Deusch, K., Oberstadt, K., Schaedel, W., Weber, M., Classen, M. (1993). P-ANCA as a Diagnostic Marker in Ulcerative Colitis. In: Gross, W.L. (eds) ANCA-Associated Vasculitides. Advances in Experimental Medicine and Biology, vol 336. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9182-2_96

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9182-2_96

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9184-6

  • Online ISBN: 978-1-4757-9182-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics